- Home
- ZTO vs RPRX Comparison
ZTO vs RPRX Comparison
Compare ZTO & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZTO
- RPRX
- Stock Information
- Founded
- ZTO 2002
- RPRX 1996
- Country
- ZTO China
- RPRX United States
- Employees
- ZTO N/A
- RPRX 99
- Industry
- ZTO Advertising
- RPRX Biotechnology: Pharmaceutical Preparations
- Sector
- ZTO Consumer Discretionary
- RPRX Health Care
- Exchange
- ZTO Nasdaq
- RPRX Nasdaq
- Market Cap
- ZTO 13.4B
- RPRX 15.6B
- IPO Year
- ZTO 2016
- RPRX 2020
- Fundamental
- Price
- ZTO $20.59
- RPRX $37.58
- Analyst Decision
- ZTO Buy
- RPRX Strong Buy
- Analyst Count
- ZTO 5
- RPRX 4
- Target Price
- ZTO $22.64
- RPRX $46.75
- AVG Volume (30 Days)
- ZTO 2.2M
- RPRX 2.6M
- Earning Date
- ZTO 08-19-2025
- RPRX 08-06-2025
- Dividend Yield
- ZTO 3.40%
- RPRX 2.34%
- EPS Growth
- ZTO N/A
- RPRX 54.86
- EPS
- ZTO 1.22
- RPRX 2.32
- Revenue
- ZTO $6,230,576,589.00
- RPRX $2,305,243,000.00
- Revenue This Year
- ZTO $15.10
- RPRX $28.60
- Revenue Next Year
- ZTO $11.79
- RPRX $8.07
- P/E Ratio
- ZTO $16.97
- RPRX $16.19
- Revenue Growth
- ZTO 14.76
- RPRX 3.02
- 52 Week Low
- ZTO $16.34
- RPRX $24.05
- 52 Week High
- ZTO $27.50
- RPRX $38.00
- Technical
- Relative Strength Index (RSI)
- ZTO 62.80
- RPRX 61.70
- Support Level
- ZTO $19.58
- RPRX $36.27
- Resistance Level
- ZTO $20.85
- RPRX $38.00
- Average True Range (ATR)
- ZTO 0.38
- RPRX 0.73
- MACD
- ZTO 0.04
- RPRX 0.01
- Stochastic Oscillator
- ZTO 85.44
- RPRX 82.89
About ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.
ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 22.1% in 2022. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 77% voting rights as of June 30, 2023. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 11.7% interest.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.